The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Heart Journal

• Publication date

  2015-08-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehv087PMID 25975657PMCID PMC4528097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Divergent muscle sympathetic responses to dynamic leg exercise in heart failure and age‐matched healthy subjects

  2015cited by this paper
• Paradoxical Muscle Sympathetic Reflex Activation in Human Heart Failure

  2015cited by this paper
• Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.

  2014cited by this paper
• Cardiac Sympathetic Afferent Denervation Attenuates Cardiac Remodeling and Improves Cardiovascular Dysfunction in Rats With Heart Failure

  2014cited by this paper
• Effects of Short-Term Continuous Positive Airway Pressure on Myocardial Sympathetic Nerve Function and Energetics in Patients With Heart Failure and Obstructive Sleep Apnea: A Randomized Study

  2014cited by this paper
• Heart Failure: a Companion to Braunwald's Heart Disease

  2014cited by this paper
• The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure.

  2014cited by this paper
• Statins and the autonomic nervous system.

  2014cited by this paper
• Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.

  2014cited by this paper
• Do high doses of AT(1)-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure?

  2013cited by this paper
• Central Rho Kinase Inhibition Restores Baroreflex Sensitivity and Angiotensin II Type 1 Receptor Protein Imbalance in Conscious Rabbits With Chronic Heart Failure

  2013cited by this paper
• Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure.

  2013cited by this paper
• Corrigendum to: ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’ [Eur J Heart Fail 2012;14: 803–869]

  2013cited by this paper
• Carotid body removal for treatment of chronic systolic heart failure.

  2013cited by this paper
• Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function.

  2013cited by this paper
• Autonomic Neural Regulation of the Immune System: Implications for Hypertension and Cardiovascular Disease

  2012cited by this paper
• Sleep Apnea and Cardiovascular Disease: A Bidirectional Relationship

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Central Angiotensin Type 1 Receptor Blockade Decreases Cardiac But Not Renal Sympathetic Nerve Activity in Heart Failure

  2012cited by this paper
• Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.

  2011cited by this paper
• Sympathetically Mediated Changes in Capacitance: Redistribution of the Venous Reservoir as a Cause of Decompensation

  2011cited by this paper
• Chapter 16 – Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure

  2011cited by this paper
• Neural control of renal function.

  2011cited by this paper
• The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.

  2010cited by this paper
• Translational medicine: the antihypertensive effect of renal denervation.

  2010cited by this paper
• Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity.

  2010cited by this paper
• Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

  2010cited by this paper
• Relationship between sleep apnoea and mortality in patients with ischaemic heart failure

  2009cited by this paper
• Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure

  2009cited by this paper
• Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.

  2009cited by this paper
• Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction.

  2009cited by this paper
• Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias.

  2008cited by this paper
• Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure?

  2008cited by this paper
• Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex.

  2007cited by this paper
• Luminal antigens access late endosomes of intestinal epithelial cells enriched in MHC I and MHC II molecules: in vivo study in Crohn's ileitis.

  2007cited by this paper
• Carotid Chemoreceptor Modulation of Regional Blood Flow Distribution During Exercise in Health and Chronic Heart Failure

  2007cited by this paper
• Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure.

  2007cited by this paper
• Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.

  2006cited by this paper
• Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea.

  2006cited by this paper
• Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure

  2006cited by this paper
• Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea

  2005cited by this paper
• Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Vagal heart rate responses to chronic beta‐blockade in human heart failure relate to cardiac norepinephrine spillover

  2005cited by this paper
• Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.

  2005cited by this paper
• Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.

  2005cited by this paper
• AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure.

  2004cited by this paper
• Superoxide Mediates Sympathoexcitation in Heart Failure: Roles of Angiotensin II and NAD(P)H Oxidase

  2004cited by this paper
• Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart Failure

  2003cited by this paper
• Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.

  2003cited by this paper
• Chemoreflexes--physiology and clinical implications.

  2003cited by this paper
• Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure

  2002cited by this paper
• Candesartan and Arterial Baroreflex Sensitivity and Sympathetic Nerve Activity in Patients with Mild Heart Failure

  2002cited by this paper
• The "unsympathetic" nervous system of heart failure.

  2002cited by this paper
• The inflammatory reflex

  2002cited by this paper
• Muscle Ergoreceptor Overactivity Reflects Deterioration in Clinical Status and Cardiorespiratory Reflex Control in Chronic Heart Failure

  2001cited by this paper
• Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure.

  2001cited by this paper
• Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure

  2001cited by this paper
• Respiratory Modulation of Muscle Sympathetic Nerve Activity in Patients With Chronic Heart Failure

  2001cited by this paper
• Arterial Baroreceptor and Cardiopulmonary Reflex Control of Sympathetic Outflow in Human Heart Failure

  2001cited by this paper
• Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise.

  2001cited by this paper
• Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure.

  2001cited by this paper
• Nonselective Versus Selective &bgr;-Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity

  2001cited by this paper
• Volume expansion potentiates cardiac sympathetic afferent reflex in dogs.

  2001cited by this paper
• Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure.

  2001cited by this paper
• A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure.

  1999cited by this paper
• Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure.

  1999cited by this paper
• Ganglionic mechanisms contribute to diminished vagal control in heart failure.

  1999cited by this paper
• Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.

  1999cited by this paper
• Baroreflex control of sympathetic nerve activity in essential and secondary hypertension.

  1998cited by this paper
• Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.

  1997cited by this paper
• Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure.

  1997cited by this paper
• Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans.

  1997cited by this paper
• Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.

  1997cited by this paper
• ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.

  1997cited by this paper
• Neural control of renal function.

  1997cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use

  1996cited by this paper
• Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• Cardiac sympathetic afferent reflex in dogs with congestive heart failure.

  1996cited by this paper
• Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

  1996cited by this paper
• Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.

  1996cited by this paper
• Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

  1996cited by this paper
• Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.

  1995cited by this paper
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.

  1995cited by this paper
• Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.

  1995cited by this paper
• Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.

  1995cited by this paper
• Symptoms and quality of life in heart failure: the muscle hypothesis.

  1994cited by this paper
• Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry

  1993cited by this paper
• Distribution of Left Ventricular Sympathetic Afferents Demonstrated by Reflex Responses to Transmural Myocardial Ischemia and to Intracoronary and Epicardial Bradykinin

  1993cited by this paper
• Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure.

  1993cited by this paper
• Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.

  1993cited by this paper
• Effects of aging on baroreflex regulation of sympathetic activity in humans.

  1992cited by this paper
• Effects of heart failure on baroreflex control of sympathetic neural activity.

  1992cited by this paper
• Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.

  1990cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Interaction of Cardiovascular Reflexes in Circulatory Control

  1983cited by this paper
• Is there autonomic impairment in congestive (dilated) cardiomyopathy?

  1981cited by this paper
• Defective cardiac parasympathetic control in patients with heart disease.

  1971cited by this paper

• Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images

  2026cites this paper
• Hypoxic responsiveness and gut fermentation capacity in heart failure patients: preliminary results

  2026cites this paper
• A fully degradable triboelectric vagus nerve stimulator for attenuating cardiac remodeling and heart failure at different stages

  2026cites this paper
• Pharmacological Therapy of HFrEF in 2025: Navigating New Advances and Old Unmet Needs in An Eternal Balance Between Progress and Perplexities

  2025cites this paper
• Reply to ‘Mechanisms of exercise sympathetic excitation in heart failure: the role of pulmonary artery mechanoreceptors’

  2025cites this paper
• Acute effects of beetroot extract and resveratrol ingestion on cardiovascular and cardiac autonomic modulation recovery after moderate-intensity aerobic exercise in individuals with coronary artery disease: a triple-blinded, randomized, placebo-controlled trial

  2025cites this paper
• Emerging trends and clinical challenges in AI-enhanced emotion diagnosis using physiological data

  2025cites this paper
• Individualized paced deep breathing training with autonomic nervous function as rehab targets in patients with chronic heart failure: a randomized clinical trial

  2025cites this paper
• Mediating role of neutrophil-percentage-to-albumin ratio in the association between stroke and heart failure among U.S. adults.

  2025cites this paper
• Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system.

  2025cites this paper
• Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure

  2025cites this paper
• Atrial fibrillation, sinoatrial and atrioventricular node dysfunction in a mouse model of heart failure with preserved ejection fraction

  2025cites this paper
• Systolic and diastolic dysfunction is exacerbated by age and spinal cord injury in male and female mice with central nervous system serotonin deficiency

  2025cites this paper
• Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices.

  2025cites this paper
• Dissecting the exercise pressor reflex in heart failure: A multi-step failure

  2025cites this paper
• Prestroke sleep and stroke: a narrative review

  2025cites this paper
• Mechanisms of sympathetic excitation during cycling exercise in heart failure with reduced ejection fraction

  2025cites this paper
• Wirkt die moderne pharmakologische Herzinsuffizienztherapie antiarrhythmisch?

  2025cites this paper
• Reinstating respiratory heart rate variability improves hemodynamic responses during exercise in heart failure with reduced ejection fraction

  2025cites this paper
• Research Progress in Cardiovascular Autonomic Dysfunction in Patients with Heart Failure

  2025cites this paper
• Myocardial Work’s Impact in the Evaluation of Advanced Heart Failure

  2025cites this paper
• Heart and brain interactions in heart failure: pathophysiological mechanisms and clinical perspectives

  2025cites this paper
• Physiological Responses to Sit-to-Stand and Six-Minute Walk Tests in Heart Failure: A Randomised Trial.

  2025cites this paper
• Immediate pharmacotherapy intensification after cardiac resynchronization therapy: incidence, characteristics, and impact

  2024cites this paper
• Autonomic neuromodulation for cardiomyopathy associated with metabolic syndrome - Prevention of precursors for heart failure with preserved ejection fraction-

  2024cites this paper
• Heart rate dynamics and asymmetry during sympathetic activity stimulation and post-stimulation recovery in ski mountaineers—a pilot exploratory study

  2024cites this paper
• Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure

  2024cites this paper
• Heart Rate Variability and Heart Failure with Reduced Ejection Fraction: A Systematic Review of Literature

  2024cites this paper
• Neuroimmune cross-talk in heart failure.

  2024cites this paper
• Exploration of cardiac rehabilitation nursing for elderly patients with myocardial infarction based on individualized cardiac rehabilitation

  2024cites this paper
• Cardiovascular autonomic dysfunction precedes cardiovascular disease and all‐cause mortality: 11‐year follow‐up in the ADDITION‐PRO study

  2024cites this paper
• Immediate recovery after an exercise session associated with beetroot and resveratrol intake in coronary artery disease patients: A randomised crossover trial

  2024cites this paper
• An endogenous cholinergic system controls electrical conduction in the heart

  2024cites this paper
• Physiological states and body postures can tell your flow experience——application of BP neural networks

  2024cites this paper
• The chronobiology of human heart failure: clinical implications and therapeutic opportunities

  2024cites this paper
• Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis

  2024cites this paper
• Baroreflex activation therapy in advanced heart failure: A long‐term follow‐up

  2024cites this paper
• Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure

  2024cites this paper
• Impaired Cardiopulmonary Baroreflex Function and Altered Cardiovascular Responses to Hypovolemia in Patients with Heart Failure with Preserved Ejection Fraction.

  2024cites this paper
• Effect of Optimal Heart Rate on Left Ventricular Remodeling in Patients with Systolic Heart Failure Following Acute Coronary Syndrome.

  2024cites this paper
• Treating heart failure by targeting the vagus nerve

  2024cites this paper
• Gliflozines use in heart failure patients. Focus on renal actions and overview of clinical experience.

  2024cites this paper
• Ultrasound-driven piezoelectret-based nanogenerator stimulates vagus nerve for myocardial infarction treatment

  2024cites this paper
• Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review

  2024cites this paper
• Sympathetic Response to 1-Leg Cycling Exercise Predicts Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction

  2024cites this paper
• Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction

  2024cites this paper
• Chronic intermittent hypoxia remodels catecholaminergic nerve innervation in mouse atria

  2023cites this paper
• Basic Science of Cardiac Contractility Modulation Therapy: Molecular and Electrophysiological Mechanisms.

  2023cites this paper
• Commonalities and differences in carotid body dysfunction in hypertension and heart failure

  2023cites this paper
• Consequences of group III/IV afferent feedback and respiratory muscle work on exercise tolerance in heart failure with reduced ejection fraction

  2023cites this paper
• Water drinking during aerobic exercise improves the recovery of non-linear heart rate dynamics in coronary artery disease: crossover clinical trial

  2023cites this paper
• Immunomodulation and immunopharmacology in heart failure

  2023cites this paper
• Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience

  2023influential citation
• Chronic vagus nerve stimulation in patients with heart failure: challenge or failed translation?

  2023cites this paper
• The sympathetic nervous system in heart failure revisited

  2023cites this paper
• Effects of high intensity interval-based inspiratory muscle training in patients with heart failure: A single-blind randomized controlled trial.

  2023cites this paper
• Hypertensive Heart Failure

  2023cites this paper
• The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF

  2023cites this paper
• Heart failure related central sympathetic activation: debunking the ‘holy grail’?

  2023cites this paper
• Comparison of Hemodynamic Response between Patients with Systolic Heart Failure Differing in Serum Aldosterone Concentrations during and after a 6-Minute Walk Test

  2023cites this paper
• Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?

  2023cites this paper
• Entropy of Heart Rate on Self-Selected Interval Exercises in Older Women.

  2023cites this paper
• Pulmonary Artery Denervation As A New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Age-associated global DNA hypermethylation augments the sensitivity of hearts towards ischemia-reperfusion injury

  2022cites this paper
• Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)

  2022cites this paper
• Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.

  2022cites this paper
• The Role of Remote Monitoring-Derived Heart Rates in the Risk Stratification of Heart Failure with Reduced Ejection Fraction: New Insights.

  2022cites this paper
• Effects of resistance added on aerobic training on autonomic function in cardiac patients

  2022cites this paper
• Autonomic modulation in heart failure patients by cardiopulmonary rehabilitation: who benefits?

  2022cites this paper
• Influence of sex and age on the relationship between aerobic fitness and muscle sympathetic nerve activity in healthy adults.

  2022cites this paper
• Treatment of Cheyne-Stokes Respiration in Heart Failure with Adaptive Servo-Ventilation: An Integrative Model.

  2022cites this paper
• Current and future use of neuromodulation in heart failure

  2022cites this paper
• A Meta-analysis of the efficacy of pulmonary artery denervation in the treatment of pulmonary hypertension.

  2022cites this paper
• Iron repletion in heart failure: a central chemoreceptor reflex tonic?

  2022cites this paper
• Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy

  2022cites this paper
• Effects of Chronic Mild Stress on Cardiac Autonomic Activity, Cardiac Structure and Renin–Angiotensin–Aldosterone System in Male Rats

  2022cites this paper
• Autonomic imbalance and atrial ectopic activity—a pathophysiological and clinical view

  2022cites this paper
• Brain, heart, and sudden death

  2022cites this paper
• Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure.

  2022cites this paper
• Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.

  2022cites this paper
• Treatment of Heart Failure with reduced Ejection Fraction in 2022: The Essential Pillars

  2022cites this paper
• Preventive aerobic training preserves sympathovagal function and improves DNA repair capacity of peripheral blood mononuclear cells in rats with cardiomyopathy

  2022cites this paper
• Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice

  2022cites this paper
• Sleep Breathing Disorders in Heart Failure.

  2022cites this paper
• EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS

  2022cites this paper
• A Methodological Perspective on the Function and Assessment of Peripheral Chemoreceptors in Heart Failure: A Review of Data from Clinical Trials

  2022cites this paper
• Contribution of Peripheral Chemoreceptors to Exercise Intolerance in Heart Failure

  2022cites this paper
• Baroreflex activation therapy in heart failure: targeting the right patient

  2022cites this paper
• Autonomic cardiovascular reflex control of hemodynamics during exercise in heart failure with reduced ejection fraction and the effects of exercise training.

  2022influential citation
• Normal and excessive muscle sympathetic nerve activity in heart failure: implications for future trials of therapeutic autonomic modulation

  2022cites this paper
• Effects of overweight and smoking on aerobic capacity, autonomic and pulmonary function in physically inactive middle-aged male

  2021influential citation
• Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective

  2021cites this paper
• Association Between Arousals During Sleep and Hypertension Among Patients With Obstructive Sleep Apnea

  2021cites this paper
• [Takotsubo syndrome after palliative transcatheter treatment of acquired aortic stenosis in patient with congenital ventricular septal defect. Case report].

  2021cites this paper
• The sympathies of the body: functional organization and neuronal differentiation in the peripheral sympathetic nervous system

  2021cites this paper
• Sympathetic activation in heart failure with reduced and mildly reduced ejection fraction: the role of aetiology

  2021cites this paper
• Subclinical cardiac damage in cancer patients before chemotherapy

  2021cites this paper
• Sympathetic vasoconstrictor activity before and after left ventricular assist device implantation in patients with end‐stage heart failure

  2021cites this paper
• Selective Neuromodulation of the Vagus Nerve

  2021cites this paper
• The 2021 Carl Ludwig Lecture. Unsympathetic autonomic regulation in heart failure: patient-inspired insights.

  2021cites this paper